Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-11

Clinical Trial Update: Study of TurnCare's Q-2 System on the Sacral Pressure Ulcer Prevention in High Risk Patients [NA]

View source ↗

Summary

This clinical trial update concerns TurnCare's Q-2 System for preventing sacral pressure ulcers in high-risk patients. The study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Q-2 System

Snippet

Sponsor: TurnCare Inc. | Conditions: Pressure Ulcer, Buttock | NA | Status: UNKNOWN